Title:
スタフィロコッカス・エピダーミジス関連I及びII型表面抗原
Document Type and Number:
Japanese Patent JP4087896
Kind Code:
B2
Abstract:
A process is disclosed for culturing clinical Staphylococcus epidermidis cells that reproducibly enables identification of a limited number of predominant serotypes. Two predominant serotypes common to most clinical cases of S. epidermidis have been identified and are denoted Type I and Type II. A particular polysaccharide surface antigen is associated with each of the Type I and Type II serotypes. The surface antigens can be used to provide active and passive immunization against S. epidermidis infection and to produce a hyperimmune immunoglobulin or antibodies for treatment of S. epidermidis infection.
Inventors:
Huattom, Ali Ibrahim
Light, day craig
Karakawa, Walter Doubler
Light, day craig
Karakawa, Walter Doubler
Application Number:
JP50941193A
Publication Date:
May 21, 2008
Filing Date:
November 20, 1992
Export Citation:
Assignee:
Navi Biopharmaceuticals
Ali Ibrahim Huattom
Day Craig Wright
Ali Ibrahim Huattom
Day Craig Wright
International Classes:
A61K39/085; A61K39/395; A61K39/00; A61K39/002; A61K39/09; A61P31/04; A61P37/04; C07K14/195; C07K14/41; C07K14/705; C07K16/00; C07K16/12; C12P19/04; C12Q1/14; G01N33/569
Other References:
国際公開第90/03398号パンフレット
THE JOURNAL OF INFECTIOUS DISEASE, 1988, Vol.157, No.4, pp713-722
特表平1-500036号公報
Current Topics in Microbiology and Immunology, 1989, Vol.146, pp169-180
THE JOURNAL OF INFECTIOUS DISEASE, 1988, Vol.157, No.4, pp713-722
特表平1-500036号公報
Current Topics in Microbiology and Immunology, 1989, Vol.146, pp169-180
Attorney, Agent or Firm:
Yoshio Kawaguchi